Treatment of relapse of breast cancer after adjuvant systemic therapy — Review and guidelines for future research
- 31 December 1994
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 30 (1), 106-111
- https://doi.org/10.1016/s0959-8049(05)80029-2
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancerEuropean Journal Of Cancer, 1993
- Effect of adjuvant systemic therapy on response to treatment after relapseCancer Treatment Reviews, 1993
- Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancerCancer Treatment Reviews, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1991
- P-Glycoprotein expression in treated and untreated human breast cancerBritish Journal of Cancer, 1989
- Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancerBreast Cancer Research and Treatment, 1989
- Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapyCancer, 1986
- Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensCancer, 1981